Maravai Lifesciences Holdings (MRVI) Non Operating Income (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Non Operating Income of -$494000.0 in Q1 2026, down 1048.84% quarter-over-quarter from -$43000.0 in Q4 2025, and down 2158.33% on a YoY basis from $24000.0 in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Non Operating Income (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Non Operating Income history runs 7 years deep, the most recent figure standing at -$494000.0 for Q1 2026.
- In Q1 2026, Non Operating Income fell 2158.33% year-over-year to -$494000.0; the TTM figure through Mar 2026 stood at -$4.7 million (down 92.74% YoY), while the FY2025 annual figure was -$4.2 million, down 77.36% from the prior year.
- Non Operating Income was -$494000.0 for Q1 2026 at Maravai Lifesciences Holdings, down from -$43000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $914000.0 in Q4 2022 to a low of -$4.1 million in Q2 2025.
- Historically, Non Operating Income has averaged -$510705.9 across 5 years, with a median of $7000.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income plunged 42400.0% in 2022, then soared 2300.0% in 2023.
- A 5-year view of Non Operating Income shows it stood at $914000.0 in 2022, then sank by 94.64% to $49000.0 in 2023, then fell by 12.24% to $43000.0 in 2024, then tumbled by 200.0% to -$43000.0 in 2025, then plunged by 1048.84% to -$494000.0 in 2026.
- The last three Non Operating Income figures came in at -$494000.0 (Q1 2026), -$43000.0 (Q4 2025), and -$71000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 9.35 Mn |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn | -494,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -494,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Sep 30, 2025 | -71,000.00 |
| Jun 30, 2025 | -4.06 Mn |
| Mar 31, 2025 | 24,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Sep 30, 2024 | 72,000.00 |
| Jun 30, 2024 | -2.56 Mn |
| Mar 31, 2024 | 106,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 66,000.00 |
| Jun 30, 2023 | -1.62 Mn |
| Mar 31, 2023 | 168,000.00 |
| Dec 31, 2022 | 914,000.00 |
| Sep 30, 2022 | -4,000.00 |
| Jun 30, 2022 | -1.28 Mn |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 201,000.00 |
| Sep 30, 2021 | 78,000.00 |
| Jun 30, 2021 | -3,000.00 |